Mak, B., Tran, B., Thomas, H., Walker, R., Pashankar, F., Feldman, D. R., Hansen, A. R., Huddart, R. A., Dunwoodie, E., Wheater, M., Stevanovic, A. G., Mazhar, D., Lawrence, N. J., Birtle, A. J., Oladipo, O., Wyld, D., Balagtas, J. M. S., Stockler, M. R., Grimison, P. S. (2026). P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for individuals aged 11-50 years with intermediate and poor-risk metastatic germ cell tumours (GCTs).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.tps623